Reis Joaquim C, Travado Luzia, Seixas Elsa, Sousa Berta, Antoni Michael H
Institute of Biophysics and Biomedical Engineering, Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Brain Behav Immun Health. 2022 Feb 22;21:100433. doi: 10.1016/j.bbih.2022.100433. eCollection 2022 May.
Greater inflammatory signaling has been shown to promote breast cancer disease progression and poorer clinical outcomes. Lower social support and social well-being have been related to greater inflammatory signaling and poorer clinical outcomes in women with non-metastatic breast cancer, and this appears to be independent of depression. However, little is known about these associations in women with metastatic disease. s100A8/A9 and interleukin 1 beta (IL-1β) proteins are widely studied in breast cancer and are considered as biomarkers of cancer progression or as having a causal role in carcinogenesis and cancer progression and metastasis via inflammatory signaling. The aim of this study was to examine the associations between less social/family well-being (SWB) and S100A8/A9 and IL-1β levels in women diagnosed with metastatic breast cancer. Sixty women (Mean age 58.95 ± 1.49) with a diagnosis of metastatic breast cancer participated in the study. The Functional Assessment of Cancer Therapy (FACT) social and family well-being (SWB) subscale and the Hospital Anxiety Depression Scale (HADS) were administered to patients undergoing a first- or second-line endocrine or oral chemotherapy treatment and who were not experiencing brain metastasis or visceral crisis. Salivary s100A8/A9 and IL-1β levels were assessed at 5PM on two consecutive days and averaged. Multiple regression tested the independent contribution of SWB on s100 A8/A9 and IL-1b while controlling for depression. Lower levels of SWB were associated with greater S100A8/A9 (ß = -0.345, p = 0.007) and IL-1β (ß = -0.286, p = 0.027) levels and these associations remained significant after controlling for depression. This work provides new evidence for the role of decreased SWB and greater s100A8/A9 and IL-1b levels in patients diagnosed with metastatic breast cancer. Psychosocial interventions that promote social support and positive social interactions through interpersonal skills may help metastatic breast cancer patients to improve their SWB. This may have salutary effects on cancer-promoting processes, which could provide psychological and physical health benefits.
已有研究表明,更强的炎症信号会促进乳腺癌病情进展,并导致更差的临床预后。社会支持和幸福感较低与非转移性乳腺癌女性更强的炎症信号及更差的临床预后有关,而且这似乎与抑郁无关。然而,对于转移性疾病女性中的这些关联,人们了解甚少。S100A8/A9和白细胞介素1β(IL-1β)蛋白在乳腺癌中得到了广泛研究,被视为癌症进展的生物标志物,或者在致癌、癌症进展和转移过程中通过炎症信号发挥因果作用。本研究的目的是探讨社会/家庭幸福感(SWB)较低与确诊为转移性乳腺癌的女性中S100A8/A9和IL-1β水平之间的关联。60名确诊为转移性乳腺癌的女性(平均年龄58.95±1.49)参与了该研究。对接受一线或二线内分泌或口服化疗治疗、未发生脑转移或内脏危象的患者进行了癌症治疗功能评估(FACT)社会和家庭幸福感(SWB)子量表以及医院焦虑抑郁量表(HADS)的测评。在连续两天的下午5点评估唾液中S100A8/A9和IL-1β水平,并计算平均值。多元回归分析在控制抑郁的情况下,测试了SWB对S100A8/A9和IL-1β的独立贡献。SWB水平较低与更高的S100A8/A9(β=-0.345,p=0.007)和IL-1β(β=-0.286,p=0.027)水平相关,在控制抑郁后,这些关联仍然显著。这项研究为SWB降低以及S100A8/A9和IL-1β水平升高在确诊为转移性乳腺癌的患者中的作用提供了新的证据。通过人际交往技能促进社会支持和积极社会互动的心理社会干预措施,可能有助于转移性乳腺癌患者改善其SWB。这可能对癌症促进过程产生有益影响,从而带来心理和身体健康益处。